iRhythm Technologies, Inc.
Health
Performance
4.5
Risk
Sell
Buy
Curious about the Scores? Learn more.

iRhythm Technologies, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

16.01.2026
Short-term strength kicking in. Early signs of life.
11.01.2026
On shaky ground. Struggling to find a clear direction.
10.01.2026
Risk creeping up. Stability not bulletproof anymore.
20.08.2025
Pulse detected. Still fragile, but stabilizing.

iRhythm Technologies, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does iRhythm Technologies, Inc. do? Business model and key facts

Get the full picture of iRhythm Technologies, Inc.: what it builds, where it operates, and how it makes money.

iRhythm Technologies, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 2000

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

shop
Company facts
Quentin S. Blackford
CEO
2000
Employees worldwide
shop
Performance
66.77%
Last 12 months
-31.34%
Last 5 years
shop
Growth
$591,84M
Revenue year
$0
Net income
shop
Valuation
$5,54B
Market Cap
-24.83
Price/Earnings Ratio

Stocks related to iRhythm Technologies, Inc.

Selected based on industry alignment and relative market positioning.

GKOS
Glaukos Corporation
114.48
+9.62%
8.2
Sell
Buy
Glaukos Corporation
BRKR
Bruker Corporation
49.46
+0.65%
7.3
Sell
Buy
Bruker Corporation
BIO
Bio-Rad Laboratories, Inc.
322.06
+1.20%
4.9
Sell
Buy
Bio-Rad Laboratories, Inc.
TMDX
TransMedics Group, Inc.
143.69
+1.22%
6.1
Sell
Buy
TransMedics Group, Inc.
LIVN
LivaNova PLC
63.19
+3.83%
5.5
Sell
Buy
LivaNova PLC

iRhythm Technologies, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.